Prosecution Insights
Last updated: April 19, 2026

Medshine Discovery Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18569867 BENZOXAZINONE DERIVATIVES COUGHLIN, MATTHEW P 1626 Non-Final OA Dec 13, 2023
18550468 6-CARBAMATE SUBSTITUTED HETEROARYL RING DERIVATIVES FETTEROLF, BRANDON J 1626 Non-Final OA Sep 14, 2023
18549366 BICYCLIC PHENOL COMPOUNDS AND USE THEREOF MOTEVALLI, OROD 1628 Non-Final OA Sep 07, 2023
18263702 SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES HABTE, KAHSAY 1624 Non-Final OA Jul 31, 2023
18001429 CONJUGATE GROUP AND CONJUGATE SHIAO, YIH-HORNG 1691 Final Rejection Dec 09, 2022
17906557 PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME HASTINGS, ALISON AZAR 1627 Non-Final OA Sep 16, 2022

Managing Medshine Discovery Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month